One small nondiabetic study showed a 6.5% weight loss with sitagliptin versus 7.65% with metformin, but larger studies in T2DM have not confirmed a direct effect on weight
As reported by the American Journal of Managed Care, the approval of an oral semaglutide formulation marked the beginning of what many are calling the oral GLP-1 era. In December 2025, the FDA approved the Wegovy (semaglutide) tablet as the first once-daily oral GLP-1 receptor agonist indicated for chronic weight management in adults with obesity or overweight
Blood sugar was higher on days that they drank coffee than it was on days they didnt
In 2025, the American Feed Industry Association reported continued expansion in commercial feed output, underscoring the industrys emphasis on performance-enhancing additives to protect farm margins [9]
You already use the app for meals, recipes, macros, activity, or connected devices